Table 1.
Experimental group |
Equimolar | 100× | 250× | 500× |
---|---|---|---|---|
GSH | −7.1 ± 10.3 | −47.3 ± 5.6 * | −52.8 ± 6.8 * | −60.6 ± 4.7 * |
NAC | −22.0 ± 9.8 | −47.3 ± 4.3 * | −61.5 ± 11.6 * | −57.2 ± 6.3 * |
GSSG | −8.3 ± 9.4 | −12.9 ± 10.6 | −13.0 ± 11.0 | −1.1 ± 13.2 |
Single-dose experiments | ||||
Endostatin (10 μg/ml) | +4.2 ± 14.4 | |||
Endostatin (10 μg/ml) + 250 × NAC | −43.5 ± 9.0 | |||
EDTA (10 mM) | −95.4 ± 0.02 |
N = 5 for each experimental group, mean percentage change in MMP-9 activity ± SEM.
p < 0.05, Yates corrected χ2 test.